Role of Folate in Colon Cancer Development and Progression

Journal of Nutrition

Volumn 133, Issue 11 SUPPL. 1, 2003, Pages

  Kim, Young In ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Animal models; Chemoprevention; Colorectal cancer; Folate

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AMINO ACID; CASEIN; DIMETHYLHYDRAZINE; DNA; FOLIC ACID; TUMOR MARKER;

CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA METHYLATION; DNA REPAIR; DYSPLASIA; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENETIC PREDISPOSITION; HUMAN; NONHUMAN; ULCERATIVE COLITIS;

ANIMALIA; RODENTIA;

EID: 0242610825     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.11.3731s     Document Type: Conference Paper

References (94)

1. The Homocysteine Studies Collaboration. (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J. Am. Med. Assoc. 288: 2015-2022.
2. Boushey, C. J., Beresford, S. A., Omenn, G. S. & Motulsky, A. G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274: 1049-1057.
3. Ray, J. G. (1998) Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch. Intern. Med. 158: 2101-2106.
4. MRC Vitamin Study Research Group. (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-137.
5. Berry, R. J., Li, Z., Erickson, J. D., Li, S., Moore, C. A., Wang, H., Mulinare, J., Zhao, P., Wong, L. Y., Gindler, J., Hong, S. X. & Correa, A. (1999) Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N. Engl. J. Med. 341: 1485-1490.
6. Vollset, S. E., Refsum, H., Irgens, L. M., Emblem, B. M., Tverdal, A., Gjessing, H. K., Monsen, A. L. & Ueland, P. M. (2000) Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am. J. Clin. Nutr. 71: 962-968.
7. George, L., Mills, J. L., Johansson, A. L., Nordmark, A., Olander, B., Granath, F. & Cnattingius, S. (2002) Plasma folate levels and risk of spontaneous abortion. J. Am. Med. Assoc. 288: 1867-1873.
8. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. & Wolf, P. A. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346: 476-483.
9. U.S. Food and Drug Administration. (1996) Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. 21 CFR Parts 136, 137, and 139. Fed. Regist. 61: 8781-8807.
10. Health Canada. (1997) Regulations amending the Food and Drug Regulations (1066). Canada Gazette Part 1. 131: 3702-3737.
11. Choi, S. W. & Mason, J. B. (2002) Folate status: effects on pathways of colorectal carcinogenesis. J. Nutr. 132: 2413S-2418S.
12. Kim, Y. I. (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J. Nutr. Biochem 10: 66-88.
13. Kim, Y. I. (1999) Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr. Rev. 57: 314-321.
14. Bailey, L. B., Rampersaud, G. C. & Kauwell, G. P. (2003) Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J. Nutr. 133: 1961S-1968S.
15. Giovannucci, E. (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J. Nutr. 132: 2350S-2355S.
16. Hillman, R. S. & Steinberg, S. E. (1982) The effects of alcohol on folate metabolism. Annu. Rev. Med. 33: 345-354.
17. Chen, J., Giovannucci, E., Kelsey, K., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Spiegelman, D., Willett, W. C. & Hunter, D. J. (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56: 4862-4864.
18. Ma, J., Stampfer, M. J., Giovannucci, E., Artigas, C., Hunter, D. J., Fuchs, C., Willett, W. C., Selhub, J., Hennekens, C. H. & Rozen, R. (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57: 1098-1102.
19. Slattery, M. L., Potter, J. D., Samowitz, W., Schaffer, D. & Leppert, M. (1999) Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 8: 513-518.
20. Ulrich, C. M., Kampman, E., Bigler, J., Schwartz, S. M., Chen, C., Bostick, R., Fosdick, L., Beresford, S. A., Yasui, Y. & Potter, J. D. (1999) Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol. Biomarkers Prev. 8: 659-668.
21. Kim, Y. I. (2000) Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr. Rev. 58: 205-209.
22. Eaden, J. A. & Mayberry, J. F. (2000) Colorectal cancer complicating ulcerative colitis: a review. Am. J. Gastroenterol. 95: 2710-2719.
23. Eaden, J. A., Abrams, K. R. & Mayberry, J. F. (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535.
24. Lashner, B. A., Heidenreich, P. A., Su, G. L., Kane, S. V. & Hanauer, S. B. (1989) Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology 97: 255-259.
25. Lashner, B. A. (1993) Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J. Cancer Res. Clin. Oncol. 119: 549-554.
26. Lashner, B. A., Provencher, K. S., Seidner, D. L., Knesebeck, A. & Brzezinski, A. (1997) The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112: 29-32.
27. Byers, T. (1999) What can randomized controlled trials tell us about nutrition and cancer prevention? CA Cancer J. Clin. 49: 353-361.
28. Cravo, M., Fidalgo, P., Pereira, A. D., Gouveia-Oliveira, A., Chaves, P., Selhub, J., Mason, J. B., Mira, F. C. & Leitao, C. N. (1994) DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur. J. Cancer Prev. 3: 473-479.
29. Cravo, M. L., Pinto, A. G., Chaves, P., Cruz, J. A., Lage, P., Nobre Leitao, C. & Costa Mira, F. (1998) Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake. Clin. Nutr. 17: 45-49.
30. Paspatis, G. A. & Karamanolis, D. G. (1994) Folate supplementation and adenomatous colonic polyps. Dis. Colon Rectum 37: 1340-1341.
31. Kim, Y. I., Baik, H. W., Fawaz, K., Knox, T., Lee, Y. M., Norton, R., Libby, E. & Mason, J. B. (2001) Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am. J. Gastroenterol. 96: 184-195.
32. Khosraviani, K., Weir, H. P., Hamilton, P., Moorehead, J. & Williamson, K. (2002) Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut 51: 195-199.
33. Bostick, R. M., Fosdick, L., Grandits, G. A., Lillemoe, T. J., Wood, J. R., Grambsch, P., Louis, T. A. & Potter, J. D. (1997) Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients. Cancer Epidemiol. Biomarkers Prev. 6: 1011-1019.
34. Biasco, G., Zannoni, U., Paganelli, G. M., Santucci, R., Gionchetti, P., Rivolta, G., Miniero, R., Pironi, L., Calabrese, C., Di Febo, G. & Miglioli, M. (1997) Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol. Biomarkers Prev. 6: 469-471.
35. Cravo, M., Gloria, L., Salazar De Sousa, L., Chaves, P., Dias Pereira, A., Quina, M., Nobre Leitao, C. & Costa Mira, F. (1995) Folate status, DNA methylation, and colon cancer risk in inflammatory bowel disease. Clin. Nutr. 14: 50-53.
36. Boland, C. R. (2000) Molecular genetics of hereditary nonpolyposis colorectal cancer. Ann. N Y. Acad. Sci. 910: 50-59; discussion 59-61.
37. Brentnall, T. A., Crispin, D. A., Bronner, M. P., Cherian, S. P., Hueffed, M., Rabinovitch, P. S., Rubin, C. E., Haggift, R. C. & Boland, C. R. (1996) Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 56: 1237-1240.
38. Cravo, M. L., Albuquerque, C. M., Salazar de Sousa, L., Gloria, L. M., Chaves, P., Dias Pereira, A., Nobre Leitao, C., Quina, M. G. & Costa Mira, F. (1998) Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation. Am. J. Gastroenterol. 93: 2060-2064.
39. Lashner, B. A., Shapiro, B. D., Husain, A. & Goldblum, J. R. (1999) Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am. J. Gastroenterol. 94: 456-462.
40. Brentnall, T. A., Crispin, D. A., Rabinovitch, P. S., Haggitt, R. C., Rubin, C. E., Stevens, A. C. & Burmer, G. C. (1994) Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107: 369-378.
41. Schatzkin, A. & Gail, M. (2002) The promise and peril of surrogate end points in cancer research. Nat. Rev. Cancer 2: 19-27.
42. Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., Woolf, S. H., Glick, S. N., Ganiats, T. G., Bond, J. H., Rosen, L., Zapka, J. G., Olsen, S. J., Giardiello, F. M., Sisk, J. E., Van Antwerp, R., Brown-Davis, C., Marciniak, D. A. & Mayer, R. J. (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112: 594-642.
43. Cravo, M. L., Mason, J. B., Dayal, Y., Hutchinson, M., Smith, D., Selhub, J. & Rosenberg, I. H. (1992) Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res. 52: 5002-5006.
44. Kim, Y. I., Salomon, R. N., Graeme-Cook, F., Choi, S. W., Smith, D. E., Dallal, G. E. & Mason, J. B. (1996) Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 39: 732-740.
45. Bird, R. P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93: 55-71.
46. Reddy, B. S., Wang, C. X., Aliaga, C., Rao, C. V., Lubet, R. A., Steele, V. E. & Kelloff, G. J. (1996) Potential chemopreventive activity of perillyl alcohol and enhancement of experimental colon carcinogenesis by folic acid and genistein. Proc. Am. Assoc. Cancer Res. 37: A1849.
47. Wargovich, M. J., Chen, C. D., Jimenez, A., Steele, V. E., Velasco, M., Stephens, L. C., Price, R., Gray, K. & Kelloff, G. J. (1996) Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomarkers Prev. 5: 355-360.
48. Wargovich, M. J., Jimenez, A., McKee, K., Steele, V. E., Velasco, M., Woods, J., Price, R., Gray, K. & Kelloff, G. J. (2000) Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21: 1149-1155.
49. Le Leu, R. K., Young, G. P. & McIntosh, G. H. (2000) Folate deficiency diminishes the occurrence of aberrant crypt foci in the rat colon but does not alter global DNA methylation status. J. Gastroenterol. Hepatol. 15: 1158-1164.
50. Le Leu, R. K., Young, G. P. & McIntosh, G. H. (2000) Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 21: 2261-2265.
51. Walzem, R. L. & Clifford, A. J. (1988) Folate deficiency in rats fed diets containing free amino acids or intact proteins. J. Nutr. 118: 1089-1096.
52. Kim, Y. I. (2001) Nutrition and cancer. In: Present knowledge in nutrition, 8th ed. (Bowman, B. & Russell, R., eds.), pp. 573-589. International Life Sciences Institute Press, Washington, DC.
53. Rogers, A. E. & Nauss, K. M. (1985) Rodent models for carcinoma of the colon. Dig. Dis. Sci. 30: 87S-102S.
54. Banerjee, A. & Quirke, P. (1998) Experimental models of colorectal cancer. Dis. Colon Rectum 41: 490-505.
55. Moser, A. R., Pitot, H. C. & Dove, W. F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
56. Su, L. K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A. & Dove, W. F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.
57. Min mouse. Cancer Res. 60: 5434-5440.
58. Wagner, C. (1995) Biochemical role of folate in cellular metabolism. In: Folate in health and disease (Bailey, L. B., ed.), pp. 23-42. Marcel Dekker, New York.
59. Kamen, B. (1997) Folate and antifolate pharmacology. Semin. Oncol. 24: S18-30-S18-39.
60. Little, P. A., Sampath, A. & Paganelli, V. (1948) The effect of folic acid and its antagonists on rous chicken sarcoma. Trans. N.Y. Acad. Sci. Series II 10: 91-98.
61. Rosen, F. (1962) Inhibitoin of the growth of an amethopterin-refractory tumor by dietary restriction of folic acid. Cancer Res. 22: 495-500.
62. Bills, N. D., Hinrichs, S. H., Morgan, R. & Clifford, A. J. (1992) Delayed tumor onset in transgenic mice fed a low-folate diet. J. Natl. Cancer Inst. 84: 332-337.
63. Farber, S. (1949) Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood 4: 160-167.
64. Sibani, S., Meinyk, S., Pogribny, I. P., Wang, W., Hiou-Tim, F., Deng, L., Trasler, J., James, S. J. & Rozen, R. (2002) Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. Carcinogenesis 23: 61-65.
65. Song, J., Sohn, K. J., Medline, A., Ash, C., Gallinger, S. & Kim, Y. I. (2000) Chemopreventive effects of dietary folate on intestinal polyps in Apc+/ -Msh2-/- mice. Cancer Res. 60: 3191-3199.
66. Reitmair, A. H., Cai, J. C., Bjerknes, M., Redston, M., Cheng, H., Pind, M. T., Hay, K., Mitri, A., Bapat, B. V., Mak, T. W. & Gallinger, S. (1996) MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res. 56: 2922-2926.
67. Kotsopoulos, J., Sohn, K. J., Martin, R., Choi, M., Renlund, R., McKerlie, C., Hwang, S. W., Medline, A. & Kim, Y. I. (2003) Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Carcinogenesis 24: 937-944.
68. Kotsopoulos, J., Sohn, K. J., Martin, R., Renlund, R., Hwang, S. W., Medline, A. & Kim, Y. I. (2002) Effects of dietary folate on the initiation and promotion phases of MNU-induced mammary tumorigenesis in rats. Proc. Am. Assoc. Cancer Res. 43: 512 (abs.).
69. Carrier, J., Medline, A., Sohn, K. J., Choi, M., Martin, R., Hwang, S. W. & Kim, Y. I. (2003) Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin-2 and β2-microglobulin deficient mice. Cancer Epidemiol. Biomarkers Prev. (in press).
70. Simpson, S. J., Mizoguchi, E., Allen, D., Bhan, A. K. & Terhorst, C. (1995) Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur. J. Immunol. 25: 2618-2625.
71. Shah, S. A., Simpson, S. J., Brown, L. F., Comiskey, M., de Jong, Y. P., Allen, D. & Terhorst, C. (1998) Development of colonic adenocarcinomas in a mouse model of ulcerative colitis. Inflamm. Bowel Dis. 4: 196-202.
72. Sohn, K. J., Shah, S. A., Reid, S., Choi, M., Carrier, J., Comiskey, M., Terhorst, C. & Kim, Y. I. (2001) Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and beta(2)-microglobulin-deficient mouse. Cancer Res. 61: 6912-6917.
73. Campbell, N. R. (1996) How safe are folic acid supplements? Arch. Intern. Med. 156: 1638-1644.
74. Center for Disease Control and Prevention. (2000) Folate status in women of childbearing age - United States. MMWR 49: 962-965.
75. Choumenkovitch, S. F., Jacques, P. F., Nadeau, M. R., Wilson, P. W., Rosenberg, I. H. & Selhub, J. (2001) Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J. Nutr. 131: 3277-3280.
76. Choumenkovitch, S. F., Selhub, J., Wilson, P. W., Rader, J. J., Rosenberg, I. H. & Jacques, P. F. (2002) Folic acid intake from fortification in United States exceeds predictions. J. Nutr. 132: 2792-2798.
77. Jacques, P. F., Selhub, J., Bostom, A. G., Wilson, P. W. & Rosenberg, I. H. (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N. Engl. J. Med. 340: 1449-1454.
78. Lawrence, J. M., Petitti, D. B., Watkins, M. & Umekubo, M. A. (1999) Trends in serum folate after food fortification. Lancet 354: 915-916.
79. Ray, J. G., Vermeulen, M. J., Boss, S. C. & Cole, D. E. (2002) Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification. Epidemiology 13: 238-240.
80. Honein, M. A., Paulozzi, L. J., Mathews, T. J., Erickson, J. D. & Wong, L. Y. (2001) Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. J. Am. Med. Assoc. 285: 2981-2986.
81. Williams, L. J., Mai, C. T., Edmonds, L. D., Shaw, G. M., Kirby, R. S., Hobbs, C. A., Sever, L. E., Miller, L. A., Meaney, F. J. & Levitt, M. (2002) Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66: 33-39.
82. Gucciardi, E., Pietrusiak, M. A., Reynolds, D. L. & Rouleau, J. (2002) Incidence of neural tube defects in Ontario, 1986-1999. Can. Med. Assoc. J. 167: 237-240.
83. Duthie, S. J. (1999) Folic acid deficiency and cancer: mechanisms of DNA instability. Br. Med. Bull. 55: 578-592.
84. Ames, B. N. (2001) DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat. Res. 475: 7-20.
85. Fenech, M. (2001) The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutat. Res. 475: 57-67.
86. Balaghi, M. & Wagner, C. (1993) DNA methylation in folate deficiency: use of CpG methylase. Biochem. Biophys. Res. Commun. 193: 1184-1190.
87. Kim, Y. J., Christman, J. K., Fleet, J. C., Cravo, M. L., Salomon, R. N., Smith, D., Ordovas, J., Selhub, J. & Mason, J. B. (1995) Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am. J. Clin. Nutr. 61: 1083-1090.
88. Kim, Y. I., Pogribny, I. P., Basnakian, A. G., Miller, J. W., Selhub, J., James, S. J. & Mason, J. B. (1997) Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am. J. Clin. Nutr. 65: 46-52.
89. Kim, Y. I., Pogribny, I. P., Salomon, R. N., Choi, S. W., Smith, D. E., James, S. J. & Mason, J. B. (1996) Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate. Am. J. Pathol. 149: 1129-1137.
90. Jacob, R. A., Gretz, D. M., Taylor, P. C., James, S. J., Pogribny, I. P., Miller, B. J., Henning, S. M. & Swendseid, M. E. (1998) Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr. 128: 1204-1212.
91. Rampersaud, G. C., Kauwell, G. P., Hutson, A. D., Cerda, J. J. & Bailey, L. B. (2000) Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 72: 998-1003.
92. Fenech, M., Aitken, C. & Rinaldi, J. (1998) Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 19: 1163-1171.
93. Duthie, S. J., Narayanan, S., Brand, G. M. & Grant, G. (2000) DNA stability and genomic methylation status in colonocytes isolated from methyl-donor-deficient rats. Eur. J. Nutr. 39: 106-111.
94. Sohn, K. J., Stempak, J. M., Reid, S., Shirwadkar, S., Mason, J. B. & Kim, Y. I. (2003) The effect of dietary folate on genomic and P53-specific DNA methylation in rat colon. Carcinogenesis 24: 81-90.